Terms: = Breast cancer AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA AND Treatment
23 results:
1. Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy.
Mayerhofer C; Sedrak MS; Hopkins JO; Li T; Tayob N; Faggen MG; Sinclair NF; Chen WY; Parsons HA; Mayer EL; Lange PB; Basta AS; Perilla-Glen A; Lederman RI; Wong AR; Tiwari A; McAllister SS; Mittendorf EA; Gibson CJ; Burstein HJ; Kim AS; Freedman RA; Miller PG
J Natl Cancer Inst; 2023 Aug; 115(8):981-988. PubMed ID: 37042724
[TBL] [Abstract] [Full Text] [Related]
2. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian cancer.
Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
[TBL] [Abstract] [Full Text] [Related]
3. Hereditary breast cancer; Genetic penetrance and current status with BRCA.
Mahdavi M; Nassiri M; Kooshyar MM; Vakili-Azghandi M; Avan A; Sandry R; Pillai S; Lam AK; Gopalan V
J Cell Physiol; 2019 May; 234(5):5741-5750. PubMed ID: 30552672
[TBL] [Abstract] [Full Text] [Related]
4. Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer.
Liu Y; Xu J; Choi HH; Han C; Fang Y; Li Y; Van der Jeught K; Xu H; Zhang L; Frieden M; Wang L; Eyvani H; Sun Y; Zhao G; Zhang Y; Liu S; Wan J; Huang C; Ji G; Lu X; He X; Zhang X
Nat Commun; 2018 Nov; 9(1):4718. PubMed ID: 30413718
[TBL] [Abstract] [Full Text] [Related]
5. p38 MAPK signaling pathway activation by phenyl benzoxime in SNU-306 cells causes induction of apoptosis.
Chen W; Tan Y; Zhang Y
Microb Pathog; 2019 Jan; 126():74-78. PubMed ID: 30347260
[TBL] [Abstract] [Full Text] [Related]
6. A Four-gene Decision Tree Signature Classification of Triple-negative breast cancer: Implications for Targeted Therapeutics.
Quist J; Mirza H; Cheang MCU; Telli ML; O'Shaughnessy JA; Lord CJ; Tutt ANJ; Grigoriadis A
Mol Cancer Ther; 2019 Jan; 18(1):204-212. PubMed ID: 30305342
[TBL] [Abstract] [Full Text] [Related]
7. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
Wang YW; Zhang W; Ma R
Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
[TBL] [Abstract] [Full Text] [Related]
8. wip1: A candidate phosphatase for cancer diagnosis and treatment.
Oghabi Bakhshaiesh T; Majidzadeh-A K; Esmaeili R
DNA Repair (Amst); 2017 Jun; 54():63-66. PubMed ID: 28385459
[TBL] [Abstract] [Full Text] [Related]
9. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of wip1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3.
Pechackova S; Burdova K; Benada J; Kleiblova P; Jenikova G; Macurek L
Oncotarget; 2016 Mar; 7(12):14458-75. PubMed ID: 26883108
[TBL] [Abstract] [Full Text] [Related]
11. Arsenic Trioxide Promotes Paclitaxel Cytotoxicity in Resistant breast cancer Cells.
Bakhshaiesh TO; Armat M; Shanehbandi D; Sharifi S; Baradaran B; Hejazi MS; Samadi N
Asian Pac J Cancer Prev; 2015; 16(13):5191-7. PubMed ID: 26225652
[TBL] [Abstract] [Full Text] [Related]
12. wip1 phosphatase as a potential therapeutic target in neuroblastoma.
Richter M; Dayaram T; Gilmartin AG; Ganji G; Pemmasani SK; Van Der Key H; Shohet JM; Donehower LA; Kumar R
PLoS One; 2015; 10(2):e0115635. PubMed ID: 25658463
[TBL] [Abstract] [Full Text] [Related]
13. Allosteric wip1 phosphatase inhibition through flap-subdomain interaction.
Gilmartin AG; Faitg TH; Richter M; Groy A; Seefeld MA; Darcy MG; Peng X; Federowicz K; Yang J; Zhang SY; Minthorn E; Jaworski JP; Schaber M; Martens S; McNulty DE; Sinnamon RH; Zhang H; Kirkpatrick RB; Nevins N; Cui G; Pietrak B; Diaz E; Jones A; Brandt M; Schwartz B; Heerding DA; Kumar R
Nat Chem Biol; 2014 Mar; 10(3):181-7. PubMed ID: 24390428
[TBL] [Abstract] [Full Text] [Related]
14. Off-target response of a wip1 chemical inhibitor in skin keratinocytes.
Lee JS; Park JR; Kwon OS; Kim H; Fornace AJ; Cha HJ
J Dermatol Sci; 2014 Feb; 73(2):125-34. PubMed ID: 24126074
[TBL] [Abstract] [Full Text] [Related]
15. Hereditary genes and SNPs associated with breast cancer.
Mahdi KM; Nassiri MR; Nasiri K
Asian Pac J Cancer Prev; 2013; 14(6):3403-9. PubMed ID: 23886119
[TBL] [Abstract] [Full Text] [Related]
16. p53-Independent expression of wild-type p53-induced phosphatase 1 (wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors.
Park JY; Song JY; Kim HM; Han HS; Seol HS; Jang SJ; Choi J
Int J Biochem Cell Biol; 2012 Jun; 44(6):896-904. PubMed ID: 22405851
[TBL] [Abstract] [Full Text] [Related]
17. Nuclear factor-kappaB (NF-kappaB) is a novel positive transcriptional regulator of the oncogenic wip1 phosphatase.
Lowe JM; Cha H; Yang Q; Fornace AJ
J Biol Chem; 2010 Feb; 285(8):5249-57. PubMed ID: 20007970
[TBL] [Abstract] [Full Text] [Related]
18. The estrogen receptor alpha pathway induces oncogenic wip1 phosphatase gene expression.
Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
[TBL] [Abstract] [Full Text] [Related]
19. Genetic alterations and oncogenic pathways associated with breast cancer subtypes.
Hu X; Stern HM; Ge L; O'Brien C; Haydu L; Honchell CD; Haverty PM; Peters BA; Wu TD; Amler LC; Chant J; Stokoe D; Lackner MR; Cavet G
Mol Cancer Res; 2009 Apr; 7(4):511-22. PubMed ID: 19372580
[TBL] [Abstract] [Full Text] [Related]
20. Gene expression profiling of breast cells induced by X-rays and heavy ions.
Roy D; Guida P; Zhou G; Echiburu-Chau C; Calaf GM
Int J Mol Med; 2008 May; 21(5):627-36. PubMed ID: 18425356
[TBL] [Abstract] [Full Text] [Related]
[Next]
